-
FDA Stops Two COVID-19 Rapid Diagnostics Tests
Lin Zhang
March 01, 2022
The coronavirus (COVID-19) pandemic has been around for more than two years. While in many ways the world is returning to normal, the wave of Omicron and continued cases of COVID-19 still need to be addressed.
-
Increased COVID-19 testing triggers demand for kit reagents
Shem Oirere
February 22, 2022
The emerging new mutations of COVID-19 is fueling the global drive for mass testing hence increasing demand for reagents for both testing kits and vaccine production especially in low- and middle-income countries.
-
Pharma Sources Insight December 2021: From the Editor
Pharma Sources Insight
December 28, 2021
Has COVID been Injecting Cash into Pharma? How is Quantum going to impact pharma?
-
Demand for High-End COVID-19 Vaccines to Drive Growth of Excipients Market
SHEM OIRERE
December 17, 2021
The COVID-19 pandemic has infected 247 million people and killed five million others as of November 01, 2021 the situation still looks grim due to the high infection rates, the prolonged SARS-CoV-2 virus...
-
Progress of Research on Key COVID-19 Treatments
Deborah Seah
December 17, 2021
At the point of writing the COVID-19 pandemic is nearing its two-year run with more than four million deaths and a total of 219 million cases worldwide. Scientists across the world are still scrambling to better understand...
-
Where Are the Oral COVID-19 Vaccines Stand Now?
Lin Zhang
December 17, 2021
The novel coronavirus, SARS-CoV-2, has led to an unprecedented international health crisis and is continuing its spread across the world, with more than 218 million confirmed cases of COVID-19, including more than 4.5 million deaths, reported to the WHO a
-
A Look at 2021 Mergers and Acquisitions
SHEM OIRERE
December 17, 2021
The COVID-19 health crisis has introduced new dynamics in the global healthcare system while pushing leading pharmaceutical companies into investing more in research and development as others are enticed into mergers...
-
Syringe Shortages Threatens to Disrupt COVID-19 Vaccination in Africa
SHEM OIRERE
November 08, 2021
The current acute shortage of syringes for administering COVID-19 vaccine in Africa and other emerging nations, is yet another indication of how disruptive the SAR-CoV-2 virus driven disease has been on the global supply chain.
-
Small Molecule and Great Potential: Oral Small Molecule COVID-19 Pharmaceutical Chemicals
PharmaSources/Xiaoyaowan
October 28, 2021
Recently, MSD announced to initiate the Phase III clinical trial of its oral small molecule COVID-19 drug - Molnupiravir (MK-4482).
-
New Progress of Key Chinese COVID-19 Drugs under Research
PharmaSources/Xiaoyaowan
October 28, 2021
With the wide spread of Delta mutant worldwide, the COVID-19 infection situation is worrisome. In addition to vaccination for prevention, drug therapy can alleviate the disease deterioration...